Steris PLC
STE: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$683.00 | Nfhfgb | Fhzxcrb |
Steris' Life Science Unit Showing Strength During Pandemic; Recovery in Healthcare Not Far Behind
Business Strategy and Outlook
Steris, headquartered in Ireland, is a dominant force in medical device sterilization, sterilizing one third of all medical devices in the world. Because it offers a full suite of sterilization solutions, from the sale of individual sterilizers to full outsourcing, Steris benefits regardless of how hospitals choose to manage sterilization. Steris also has a strong presence in the operating room, with an approximate 50% share of U.S. operating room capital equipment, including surgical tables and lights.